Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes

Launched by HEALTHPARTNERS INSTITUTE · Mar 31, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new tool designed to help people at high risk for certain hereditary cancers, like breast and ovarian cancer, or Lynch syndrome. The tool aims to improve the care these patients receive by providing personalized recommendations for testing and referrals during their doctor visits. Researchers want to find out if using this tool helps patients get better cancer prevention care and encourages them to be more involved in managing their health.

To participate, individuals must be at least 18 years old and have a confirmed genetic risk for hereditary breast and ovarian cancer or Lynch syndrome. They should also be visiting a participating primary care provider and not be up-to-date on important cancer prevention care. Participants will answer survey questions about their experiences to help researchers understand the impact of this new support tool. It's important to note that people with certain conditions like dementia or those who are currently receiving cancer treatment are not eligible for this trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria: The patient must meet all the following inclusion criteria on date of the Index Visit:
• • 1. Aged 18 years or more at index clinical encounter,
• • 2. Existing genetic testing or problem list evidence of HBOC or LS,
• • 3. Index clinical encounter is with a PCC (family practice, general internal medicine, nurse practitioner, or physician assistant) at a randomized primary care clinic during the accrual period,
• • 4. At the time of the index clinical encounter have EITHER (i) Evidence of having HBOC and not up-to- date on selected variant-specific cancer prevention care OR (ii) Evidence of having LS and not up-to-date on selected variant gene-specific cancer prevention care
• Exclusion Criteria:
• • 1. Diagnosis of dementia, OR
• • 2. Currently receiving active treatment for cancer, OR
• • 3. In long-term care, palliative care, or hospice care.